These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 22009535)

  • 1. HB-EGF and PDGF mediate reciprocal interactions of carcinoma cells with cancer-associated fibroblasts to support progression of uterine cervical cancers.
    Murata T; Mizushima H; Chinen I; Moribe H; Yagi S; Hoffman RM; Kimura T; Yoshino K; Ueda Y; Enomoto T; Mekada E
    Cancer Res; 2011 Nov; 71(21):6633-42. PubMed ID: 22009535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting.
    Pietras K; Pahler J; Bergers G; Hanahan D
    PLoS Med; 2008 Jan; 5(1):e19. PubMed ID: 18232728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crosstalk with cancer-associated fibroblasts increases the growth and radiation survival of cervical cancer cells.
    Chu TY; Yang JT; Huang TH; Liu HW
    Radiat Res; 2014 May; 181(5):540-7. PubMed ID: 24785588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions.
    Nakamura T; Matsumoto K; Kiritoshi A; Tano Y; Nakamura T
    Cancer Res; 1997 Aug; 57(15):3305-13. PubMed ID: 9242465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
    Zhang L; Yang N; Park JW; Katsaros D; Fracchioli S; Cao G; O'Brien-Jenkins A; Randall TC; Rubin SC; Coukos G
    Cancer Res; 2003 Jun; 63(12):3403-12. PubMed ID: 12810677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor cell and connective tissue cell interactions in human colorectal adenocarcinoma. Transfer of platelet-derived growth factor-AB/BB to stromal cells.
    Sundberg C; Branting M; Gerdin B; Rubin K
    Am J Pathol; 1997 Aug; 151(2):479-92. PubMed ID: 9250160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth factor-mediated interaction between tumor cells and stromal fibroblasts in an experimental model of human small-cell lung cancer.
    Sugimoto T; Takiguchi Y; Kurosu K; Kasahara Y; Tanabe N; Tatsumi K; Hiroshima K; Minamihisamatsu M; Miyamoto T; Kuriyama T
    Oncol Rep; 2005 Oct; 14(4):823-30. PubMed ID: 16142338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide.
    Shawver LK; Schwartz DP; Mann E; Chen H; Tsai J; Chu L; Taylorson L; Longhi M; Meredith S; Germain L; Jacobs JS; Tang C; Ullrich A; Berens ME; Hersh E; McMahon G; Hirth KP; Powell TJ
    Clin Cancer Res; 1997 Jul; 3(7):1167-77. PubMed ID: 9815796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane type 1-matrix metalloproteinase cleaves off the NH2-terminal portion of heparin-binding epidermal growth factor and converts it into a heparin-independent growth factor.
    Koshikawa N; Mizushima H; Minegishi T; Iwamoto R; Mekada E; Seiki M
    Cancer Res; 2010 Jul; 70(14):6093-103. PubMed ID: 20587521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The EGFR ligands amphiregulin and heparin-binding egf-like growth factor promote peritoneal carcinomatosis in CXCR4-expressing gastric cancer.
    Yasumoto K; Yamada T; Kawashima A; Wang W; Li Q; Donev IS; Tacheuchi S; Mouri H; Yamashita K; Ohtsubo K; Yano S
    Clin Cancer Res; 2011 Jun; 17(11):3619-30. PubMed ID: 21482691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-binding epidermal growth factor-like growth factor is an autocrine mediator of human prostate stromal cell growth in vitro.
    Duque JL; Adam RM; Mullen JS; Lin J; Richie JP; Freeman MR
    J Urol; 2001 Jan; 165(1):284-8. PubMed ID: 11125426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expansion of human trophoblastic spheroids is promoted by decidualized endometrial stromal cells and enhanced by heparin-binding epidermal growth factor-like growth factor and interleukin-1 β.
    Gonzalez M; Neufeld J; Reimann K; Wittmann S; Samalecos A; Wolf A; Bamberger AM; Gellersen B
    Mol Hum Reprod; 2011 Jul; 17(7):421-33. PubMed ID: 21357210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour-stroma interactions between metastatic prostate cancer cells and fibroblasts.
    Kaminski A; Hahne JC; Haddouti el-M; Florin A; Wellmann A; Wernert N
    Int J Mol Med; 2006 Nov; 18(5):941-50. PubMed ID: 17016625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous blockade of platelet-derived growth factor-receptor and epidermal growth factor-receptor signaling and systemic administration of paclitaxel as therapy for human prostate cancer metastasis in bone of nude mice.
    Kim SJ; Uehara H; Yazici S; Langley RR; He J; Tsan R; Fan D; Killion JJ; Fidler IJ
    Cancer Res; 2004 Jun; 64(12):4201-8. PubMed ID: 15205332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel anti-human HB-EGF monoclonal antibody with multiple antitumor mechanisms against ovarian cancer cells.
    Miyamoto S; Iwamoto R; Furuya A; Takahashi K; Sasaki Y; Ando H; Yotsumoto F; Yoneda T; Hamaoka M; Yagi H; Murakami T; Hori S; Shitara K; Mekada E
    Clin Cancer Res; 2011 Nov; 17(21):6733-41. PubMed ID: 21918176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new in vitro model for analyzing the biological behavior of well-differentiated squamous cell carcinoma.
    Satoh S; Toda S; Inokuchi A; Sugihara H
    Pathol Res Pract; 2005; 201(1):27-35. PubMed ID: 15807308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner.
    López-Ocejo O; Viloria-Petit A; Bequet-Romero M; Mukhopadhyay D; Rak J; Kerbel RS
    Oncogene; 2000 Sep; 19(40):4611-20. PubMed ID: 11030150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells.
    Johnson FM; Saigal B; Donato NJ
    J Cell Physiol; 2005 Nov; 205(2):218-27. PubMed ID: 15887238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6 in cervical cancer: the relationship with vascular endothelial growth factor.
    Wei LH; Kuo ML; Chen CA; Cheng WF; Cheng SP; Hsieh FJ; Hsieh CY
    Gynecol Oncol; 2001 Jul; 82(1):49-56. PubMed ID: 11426961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of anti-HB-EGF immunoliposomes for the treatment of breast cancer.
    Nishikawa K; Asai T; Shigematsu H; Shimizu K; Kato H; Asano Y; Takashima S; Mekada E; Oku N; Minamino T
    J Control Release; 2012 Jun; 160(2):274-80. PubMed ID: 22020380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.